scholarly journals Kajian Pustaka: Potensi Hypnosis untuk Mengurangi Nyeri pada Pasien yang Mendapatkan Perawatan Gigi dan Mulut

2021 ◽  
Vol 18 (2) ◽  
pp. 47
Author(s):  
Eko Mulyadi

The purpose of this literature review is to find out whether hypnosis can be used to reduce pain in patients receiving dental and oral care. Hypnosis has been used to treat acute and chronic pain, anxiety, and other positive benefits before, during and after surgery. However, in the field, the use of hypnosis is still little used and even many who doubt its effectiveness. We reviewed articles in English using keywords: hypnosis, pain, anesthesia, dental, procedure with a time span from 1846 to 2019, with 20 selected articles on google scholars, pubmed, science direct, and the national library portal of the republic of Indonesia (PNRI). , Mesmerism hypnosis and Ericsonian hypnosis have been used for anesthesia for a long time before chemical anesthesia was discovered, the use of chemical anesthesia makes hypnosis no longer used as the main anesthetic in surgery, but in certain cases such as patients with multiple chemical sensitivity or patients with contraindications for general anesthesia, hypnosis still used as the primary anesthetic in surgery, currently hypnosis is widely used in perioperative surgery. The use of hypnosis with chemical anesthetics can increase the benefits and there are no reported side effects. Conclusion: hypnosis can be used as primary anesthesia, especially in certain cases, it needs well-designed research such as randomized control trials on the use of hypnosis with chemical anesthetics, both perioperatively and intraoperatively to obtain clearer and consistent scientific information about hypnosis and chemical anesthetics.

2002 ◽  
Vol 41 (06) ◽  
pp. 233-239 ◽  
Author(s):  
C. Hausteiner ◽  
A. Drzezga ◽  
P. Bartenstein ◽  
M. Schwaiger ◽  
H. Förstl ◽  
...  

SummaryAim: Multiple chemical sensitivity (MCS) is a controversially discussed symptom complex. Patients afflicted by MCS react to very low and generally nontoxic concentrations of environmental chemicals. It has been suggested that MCS leads to neurotoxic damage or neuroimmunological alteration in the brain detectable by positron emission tomography (PET) and single photon emission computer tomography (SPECT). These methods are often applied to MCS patients for diagnosis, although they never proved appropriate. Method: We scanned 12 MCS patients with PET, hypothesizing that it would reveal abnormal findings. Results: Mild glucose hypometabolism was present in one patient. In comparison with normal controls, the patient group showed no significant functional brain changes. Conclusion: This first systematic PET study in MCS patients revealed no hint of neurotoxic or neuroimmuno-logical brain changes of functional significance.


Author(s):  
Hong-Jae Chae ◽  
Byoung-Gwon Kim ◽  
Hwan-Cheol Kim ◽  
Mi-Young Lee ◽  
Jong-Han Leem

1994 ◽  
Vol 10 (4-5) ◽  
pp. 323-326
Author(s):  
Jacob Berkson

I am Jacob B. Berkson, a 68-year-old resident of Hagerstown, Maryland. I was a trial lawyer for some 40 years. I am now retired and writing a book on Environmental Pollution and Environmental Illness, titled A Canary's Tale. I was invited to speak to you as a patient one who was poisoned by an organophosphate pesticide and who subsequently developed Multiple Chemical Sensitivity (MCS, or sometimes referred to as Environmental Illness, EI).


2013 ◽  
Vol 216 (2) ◽  
pp. 202-210 ◽  
Author(s):  
Marie Thi Dao Tran ◽  
Lars Arendt-Nielsen ◽  
Ron Kupers ◽  
Jesper Elberling

Sign in / Sign up

Export Citation Format

Share Document